Terms: = Uterine cancer AND ATRX, P46100, ZNF-HX, XNP, XH2, SHS, SFM1, RAD54, MRXHF1, MGC2094, ATR2, 546 AND Treatment
28 results:
1. Outcomes associated with treatment to all sites of disease in patients with stage IVB cancer of the cervix.
Peleg Hasson S; Felder S; Helpman L; Taylor A; Shalamov M; Abuakar S; Bauer S; Shapira-Frommer R; Greenhouse I; Korach J; Rabin T; Goldstein J; Saad A
Int J Gynecol Cancer; 2023 May; 33(5):683-691. PubMed ID: 36963801
[TBL] [Abstract] [Full Text] [Related]
2. Ovarian and uterine carcinosarcomas are sensitive in vitro and in vivo to elimusertib, a novel ataxia-telangiectasia and Rad3-related (ATR) kinase inhibitor.
Manavella DD; McNamara B; Harold J; Bellone S; Hartwich TMP; Yang-Hartwich Y; Mutlu L; Zipponi M; Demirkiran C; Verzosa MS; Altwerger G; Ratner E; Huang GS; Clark M; Andikyan V; Azodi M; Schwartz PE; Dottino PR; Choi J; Alexandrov LB; Buza N; Hui P; Santin AD
Gynecol Oncol; 2023 Feb; 169():98-105. PubMed ID: 36525930
[TBL] [Abstract] [Full Text] [Related]
3. Elimusertib (BAY1895344), a novel ATR inhibitor, demonstrates in vivo activity in atrx mutated models of uterine leiomyosarcoma.
Harold J; Bellone S; Manavella DD; Mutlu L; McNamara B; Hartwich TMP; Zipponi M; Yang-Hartwich Y; Demirkiran C; Verzosa MS; Choi J; Dong W; Buza N; Hui P; Altwerger G; Huang GS; Andikyan V; Clark M; Ratner E; Azodi M; Schwartz PE; Santin AD
Gynecol Oncol; 2023 Jan; 168():157-165. PubMed ID: 36442427
[TBL] [Abstract] [Full Text] [Related]
4. uterine Leiomyosarcoma Masquerading as a Malignant Perivascular Epithelioid Cell Tumor: A Diagnostic Challenge.
Natsume T; Yoshida H; Nishikawa T; Kikkawa N; Naka T; Kobayashi-Kato M; Tanase Y; Uno M; Ishikawa M; Kato T
Int J Surg Pathol; 2023 Aug; 31(5):778-784. PubMed ID: 36310451
[TBL] [Abstract] [Full Text] [Related]
5. Comparison of thermal ablative methods and myomectomy for the treatment of fibroids: a systematic review and meta-analysis.
Liang D; Li J; Liu D; Zhao H; Lin Y
Int J Hyperthermia; 2021; 38(1):1571-1583. PubMed ID: 34724862
[TBL] [Abstract] [Full Text] [Related]
6. Screening and Discovery of New Potential Biomarkers and Small Molecule Drugs for Cervical cancer: A Bioinformatics Analysis.
Qiu HZ; Huang J; Xiang CC; Li R; Zuo ED; Zhang Y; Shan L; Cheng X
Technol Cancer Res Treat; 2020; 19():1533033820980112. PubMed ID: 33302814
[TBL] [Abstract] [Full Text] [Related]
7. 500 Cases of High-intensity Focused Ultrasound (HIFU) Ablated uterine Fibroids and Adenomyosis.
Jeng CJ; Ou KY; Long CY; Chuang L; Ker CR
Taiwan J Obstet Gynecol; 2020 Nov; 59(6):865-871. PubMed ID: 33218403
[TBL] [Abstract] [Full Text] [Related]
8. Genetic markers and phosphoprotein forms of beta-catenin pβ-Cat552 and pβ-Cat675 are prognostic biomarkers of cervical cancer.
Scholl SM; Beal J; de Koning L; Girard E; Popovic M; de la Rochefordière A; Lecuru F; Fourchotte V; Ngo C; Floquet A; Berns EM; Kenter G; Gestraud P; von der Leyen H; Lecerf C; Puard V; Roman SR; Latouche A; Kereszt A; Balint B; Rouzier R; Kamal M
EBioMedicine; 2020 Nov; 61():103049. PubMed ID: 33096476
[TBL] [Abstract] [Full Text] [Related]
9. Risk of cervical precancer and cancer among uninsured and underserved women from 2009 to 2017.
Saraiya M; Cheung LC; Soman A; Mix J; Kenney K; Chen X; Perkins RB; Schiffman M; Wentzensen N; Miller J
Am J Obstet Gynecol; 2021 Apr; 224(4):366.e1-366.e32. PubMed ID: 33035473
[TBL] [Abstract] [Full Text] [Related]
10. Comparative study on the oncological prognosis of laparoscopy and laparotomy for stage IIA1 cervical squamous cell carcinoma.
Chen C; Fang Z; Wang Q; Li W; Li P; Wang L; Kang S; Zhu B; Lin Z; Wang X; Wang L; Fan H; Bin X; Lang J; Liu P
Eur J Surg Oncol; 2021 Feb; 47(2):346-352. PubMed ID: 32859433
[TBL] [Abstract] [Full Text] [Related]
11. Genomic Landscape of uterine Sarcomas Defined Through Prospective Clinical Sequencing.
Hensley ML; Chavan SS; Solit DB; Murali R; Soslow R; Chiang S; Jungbluth AA; Bandlamudi C; Srinivasan P; Tap WD; Rosenbaum E; Taylor BS; Donoghue MTA; Hyman DM
Clin Cancer Res; 2020 Jul; 26(14):3881-3888. PubMed ID: 32299819
[TBL] [Abstract] [Full Text] [Related]
12. Competing endogenous RNA network of endometrial carcinoma: A comprehensive analysis.
Liu J; Nie S; Liang J; Jiang Y; Wan Y; Zhou S; Cheng W
J Cell Biochem; 2019 Sep; 120(9):15648-15660. PubMed ID: 31056798
[TBL] [Abstract] [Full Text] [Related]
13. Importance of Technique, Target Selection, Contouring, Dose Prescription, and Dose-Planning in External Beam Radiation Therapy for Cervical cancer: Evolution of Practice From EMBRACE-I to II.
Berger T; Seppenwoolde Y; Pötter R; Assenholt MS; Lindegaard JC; Nout RA; de Leeuw A; Jürgenliemk-Schulz I; Tan LT; Georg D; Kirisits C; Dumas I; Nesvacil N; Swamidas J; Hudej R; Lowe G; Hellebust TP; Menon G; Fokdal L; Tanderup K;
Int J Radiat Oncol Biol Phys; 2019 Jul; 104(4):885-894. PubMed ID: 30904706
[TBL] [Abstract] [Full Text] [Related]
14. Preoperative chemoradiation followed by hysterectomy for cervical cancer: patterns of care and survival in a large, hospital database.
Albert A; Allbright R; Lee A; Vijayakumar S
J Gynecol Oncol; 2019 May; 30(3):e41. PubMed ID: 30887759
[TBL] [Abstract] [Full Text] [Related]
15. Assessment of costs associated with adverse events in patients with cancer.
Wong W; Yim YM; Kim A; Cloutier M; Gauthier-Loiselle M; Gagnon-Sanschagrin P; Guerin A
PLoS One; 2018; 13(4):e0196007. PubMed ID: 29652926
[TBL] [Abstract] [Full Text] [Related]
16. HPV-16 targeted DNA vaccine expression: The role of purification.
Almeida AM; Tomás J; Pereira P; Queiroz JA; Sousa F; Sousa Â
Biotechnol Prog; 2018 Mar; 34(2):546-551. PubMed ID: 29314780
[TBL] [Abstract] [Full Text] [Related]
17. Cervical small cell neuroendocrine tumor mutation profiles via whole exome sequencing.
Cho SY; Choi M; Ban HJ; Lee CH; Park S; Kim H; Kim YS; Lee YS; Lee JY
Oncotarget; 2017 Jan; 8(5):8095-8104. PubMed ID: 28042953
[TBL] [Abstract] [Full Text] [Related]
18. Impact of Radical Hysterectomy on Survival in Patients with Stage 2 Type1 Endometrial Carcinoma: A Matched Cohort Study.
Phelippeau J; Koskas M
Ann Surg Oncol; 2016 Dec; 23(13):4361-4367. PubMed ID: 27380636
[TBL] [Abstract] [Full Text] [Related]
19. Cervical cancer screening uptake and challenges in Malawi from 2011 to 2015: retrospective cohort study.
Msyamboza KP; Phiri T; Sichali W; Kwenda W; Kachale F
BMC Public Health; 2016 Aug; 16(1):806. PubMed ID: 27535359
[TBL] [Abstract] [Full Text] [Related]
20. Iniparib plus paclitaxel and carboplatin as initial treatment of advanced or recurrent uterine carcinosarcoma: a Gynecologic Oncology Group Study.
Aghajanian C; Sill MW; Secord AA; Powell MA; Steinhoff M
Gynecol Oncol; 2012 Sep; 126(3):424-7. PubMed ID: 22634397
[TBL] [Abstract] [Full Text] [Related]
[Next]